These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 26260899)

  • 1. Neurocognitive impairment in the deficit subtype of schizophrenia.
    Fervaha G; Agid O; Foussias G; Siddiqui I; Takeuchi H; Remington G
    Eur Arch Psychiatry Clin Neurosci; 2016 Aug; 266(5):397-407. PubMed ID: 26260899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of neurocognitive impairment with diminished expression and apathy in schizophrenia.
    Hartmann-Riemer MN; Hager OM; Kirschner M; Bischof M; Kluge A; Seifritz E; Kaiser S
    Schizophr Res; 2015 Dec; 169(1-3):427-432. PubMed ID: 26526750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General and domain-specific neurocognitive impairments in deficit and non-deficit schizophrenia.
    Réthelyi JM; Czobor P; Polgár P; Mersich B; Bálint S; Jekkel E; Magyar K; Mészáros A; Fábián A; Bitter I
    Eur Arch Psychiatry Clin Neurosci; 2012 Mar; 262(2):107-15. PubMed ID: 21792534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurocognitive deficits or stress overload: Why do individuals with schizophrenia show poor performance in neurocognitive tests?
    Krkovic K; Moritz S; Lincoln TM
    Schizophr Res; 2017 May; 183():151-156. PubMed ID: 27838097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocognitive insight and objective cognitive functioning in schizophrenia.
    Burton CZ; Harvey PD; Patterson TL; Twamley EW
    Schizophr Res; 2016 Mar; 171(1-3):131-6. PubMed ID: 26811232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward a more parsimonious assessment of neurocognition in schizophrenia: a 10-minute assessment tool.
    Fervaha G; Agid O; Foussias G; Remington G
    J Psychiatr Res; 2014 May; 52():50-6. PubMed ID: 24507885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive impairments and psychopathological parameters in patients of the schizophrenic spectrum.
    Kontaxaki MI; Kattoulas E; Smyrnis N; Stefanis NC
    Psychiatriki; 2014; 25(1):27-38. PubMed ID: 24739500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocognitive Impairments in Deficit and Non-Deficit Schizophrenia and Their Relationships with Symptom Dimensions and Other Clinical Variables.
    Yu M; Tang X; Wang X; Zhang X; Zhang X; Sha W; Yao S; Shu N; Zhang X; Zhang Z
    PLoS One; 2015; 10(9):e0138357. PubMed ID: 26381645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between insight dimensions and cognitive functions in patients with deficit and nondeficit schizophrenia.
    Pegoraro LFL; Dantas CR; Banzato CEM; Fuentes D
    Schizophr Res; 2013 Jun; 147(1):91-94. PubMed ID: 23535076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychological impairment in deficit vs. non-deficit schizophrenia.
    Cascella NG; Testa SM; Meyer SM; Rao VA; Diaz-Asper CM; Pearlson GD; Schretlen DJ
    J Psychiatr Res; 2008 Sep; 42(11):930-7. PubMed ID: 18021807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive deficit awareness in schizophrenia: absent, intact, or somewhere in-between?
    Balzan RP; Neaves A; Denson LA; Liu D; Galletly C
    Cogn Neuropsychiatry; 2014; 19(6):471-84. PubMed ID: 24749790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
    Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
    Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Building a neurocognitive profile of thought disorder in schizophrenia using a standardized test battery.
    Tan EJ; Rossell SL
    Schizophr Res; 2014 Jan; 152(1):242-5. PubMed ID: 24291545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using negative feedback to guide behavior: impairments on the first 4 cards of the Wisconsin Card Sorting Test predict negative symptoms of schizophrenia.
    Vogel SJ; Strauss GP; Allen DN
    Schizophr Res; 2013 Dec; 151(1-3):97-101. PubMed ID: 24210530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurocognitive functioning and quality of life in patients with and without deficit syndrome of schizophrenia.
    Sum MY; Tay KH; Sengupta S; Sim K
    Psychiatry Res; 2018 May; 263():54-60. PubMed ID: 29499447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decision-making capacity for research participation among individuals in the CATIE schizophrenia trial.
    Stroup S; Appelbaum P; Swartz M; Patel M; Davis S; Jeste D; Kim S; Keefe R; Manschreck T; McEvoy J; Lieberman J
    Schizophr Res; 2005 Dec; 80(1):1-8. PubMed ID: 16182516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severity of hypertension predicts the generalized neurocognitive deficit in schizophrenia.
    Morra LF; Strauss GP
    Schizophr Res; 2016 Oct; 176(2-3):527-528. PubMed ID: 27397721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Measuring the cognitive deficit associated with schizophrenia: presentation of the MATRICS neuropsychological test battery].
    Sarolta K; Pál C; István B
    Neuropsychopharmacol Hung; 2007 Oct; 9(3):143-50. PubMed ID: 18399033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Differentiation of deficit and non-deficit schizophrenia based on cognitive functions].
    Polgár P
    Ideggyogy Sz; 2011 Mar; 64(3-4):128-32. PubMed ID: 21545010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.